Phosphodiesterase 3 — Drug Target

4 drugs 3 marketed 1 in Phase 3

All drugs that target Phosphodiesterase 3 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

olprinone · Phosphodiesterase 3 Inhibitor · Phosphodiesterase 3 inhibitor

Marketed (3)

Loprinone · olprinone · Cardiovascular
Primacor · Sanofi · Phosphodiesterase 3 Inhibitor · Cardiovascular
Primacor · Sanofi · Phosphodiesterase 3 Inhibitor

Phase 3 pipeline (1)

intravenous milrinone · Konkuk University Medical Center · Phosphodiesterase 3 inhibitor · Cardiovascular
Milrinone is a phosphodiesterase 3 inhibitor that increases cardiac contractility and vasodilation.